X

Vous n'êtes pas connecté

Maroc Maroc - DESANG.NET - A la Une - 13/Jan 08:42

Fenofibrate slows diabetic retinopathy progression

Trial data has shown that the old, generic cholesterol drug fenofibrate has shown potential for slowing the progression of diabetic retinopathy in people with early retinal changes, with the potential of reducing the need for retinal laser or intravitreal injection treatment. In the LENS trial of more than 1100 people randomly assigned to fenofibrate or […]

Articles similaires

Blindness Awareness Month: Early detection key to saving sight

newsday.co.tt - 07:26

BAVINA SOOKDEO Every year, millions around the world lose their sight – not because their condition was untreatable, but because it was detected...

Blindness Awareness Month: Early detection key to saving sight

newsday.co.tt - 07:26

BAVINA SOOKDEO Every year, millions around the world lose their sight – not because their condition was untreatable, but because it was detected...

AI-driven eye screening aims to close the diabetic vision gap in community clinics

news.medical.net - 22/Oct 23:33

A new trial will evaluate whether integrating autonomous AI screening for diabetic retinopathy into U.S. federally qualified health centers can boost...

Sorry! Image not available at this time

Scientists find potential dual-action drug for diabetes, heart disease

wn.com - 11:07

MELBOURNE, Oct. 28 (Xinhua) -- An international study involving Australian scientists has identified a potential new drug that may protect against...

Sorry! Image not available at this time

Scientists find potential dual-action drug for diabetes, heart disease

wn.com - 11:07

MELBOURNE, Oct. 28 (Xinhua) -- An international study involving Australian scientists has identified a potential new drug that may protect against...

AI algorithm proves more accurate than experts in glaucoma detection

news.medical.net - 22/Oct 06:56

While artificial intelligence (AI)-powered screening has been validated for diabetic retinopathy, applying the technology to glaucoma has proved more...

Sorry! Image not available at this time

Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule

wn.com - 21/Oct 13:50

This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and pharmacokinetics of...

Which cholesterol drug is better for your heart health?

knowridge.com - 17/Oct 10:37

Rosuvastatin and atorvastatin are two of the most common medications used to lower LDL cholesterol, often called “bad” cholesterol. Doctors...

Which cholesterol drug is better for your heart health?

knowridge.com - 17/Oct 10:37

Rosuvastatin and atorvastatin are two of the most common medications used to lower LDL cholesterol, often called “bad” cholesterol. Doctors...

Health Canada authorizes long-awaited drug to slow early-stage Alzheimer's disease

innisfiltoday.ca - 27/Oct 22:50

TORONTO — Health Canada has authorized a drug shown to slow the progression of Alzheimer's disease.